New research pinpoints mechanism behind tocotrienol stroke protection

By Nathan Gray

- Last updated on GMT

Related tags Ischemic stroke

New research pinpoints mechanism behind tocotrienol stroke protection
The vitamin E compound alpha-tocotrienol may offer protection from further damage after a stroke by preventing the loss of important genetic transcripts during stroke, according to new research.

The study, published inthe Journal of Cerebral Blood Flowand Metabolism, ​sheds light on the possible mechanisms behind the suggested neuroprotective effects of alpha-tocotrienol after stroke by helping to retain important transcripts that are usually lost during an stroke event.

Professor Chandan Sen  from Ohio State University, USA, the research team used a variety of animal and cell studies to confirm that loss of the microRNA precursor (miR29) plays an important role in the development of stroke-induced neuronal injuries - adding that the vitamin E compound alpha-tocotrienol prevented these losses at the infarct site and so offered protection against neural damage.

“Micro RNAs (miR) are small non-coding RNA molecules that play important role in regulating gene expression at the translation level, and miR29 is the micro RNA in the study of stroke etiology and in many other neurodegenerative disorders including Alzheimer’s Disease,”​ explained Dr Savita Khanna - a co-researcher on the study.

"Oral supplementation of a-tocotrienol was effective in completely rescuing stroke-induced loss of both miR-29b as well as miR-29c,"​ said the researchers. "Such effect was associated with protection against stroke-induced lesion in the brain."

Study details

Sen and colleagues used a mouse model of stroke in which the mice were subjected to temporary middle-cerebral artery occlusion (MCAO) to induce stroke. At 48 hours after MCAO, there was a significant loss of miR29b at the infarct site, they confirmed.

By re-introducing miR29b at the infarct site, the team then showed that it was possible to decrease stroke-induced brain lesions by half - as compared to a control where no miR29b was reintroduced.

They noted that miR29b also significantly improved post-stroke sensorimotor functions, meaning that the group of mice that received miR29b has better agility and movement 48 hours post stroke, compared to control.

Sen then tested the effect of alpha-tocotrienol in the same mouse stroke model - giving mice 50mg/kg body weight of alpha-tocotrienol (Tocomin, Carotech Inc.) or a control that consisted of vitamin E stripped corn oil for 10 weeks before subjecting them to MCAO.

Results showed that stroke-induced loss of miR29b was completely spared in the tocotrienol supplemented group, which resulted in smaller lesion size.

Commenting on the research, WH Leong, vice president of Carotech Inc said that the findings "further strengthens the science of Tocomin for neuroprotection."

"In a stroke event, neuroprotective miR29b is loss due to the downstream product of 12-Lipoxygenase (12-Lox) called 12HETE, which leads to neuronal cell death. Tocomin is able to rescue miR29b by inhibiting 12-Lox,”​ he said.

Source: Journal of Cerebral Blood Flowand Metabolism
Published online ahead of print, doi:​ 10.1038/jcbfm.2013.68
" Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size"
Authors: Savita Khanna, et al

Related topics Research Suppliers

Related news

Show more

1 comment

Tocotrienol Dosage

Posted by Peter,

Please correct me if wrong, but given that Tocomin caps are 50 mgs in total(of which only 15 mgs is alpha-tocotrienol), at the murine dosage of 50mg/kg/day x 10 weeks (does 50mgs refer to tocomin or tocotrienol?), the amount of Tocomin or alpha-tocotrienol required in humans would be astronomical.

Report abuse

Follow us


View more